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osting by EAbstract The aim of the study was to describe a case of type II diabetic peripheral small ﬁber neu-
ropathic pain treated with whole body vibration therapy after a failed trial of conventional drugs
and interventional pain management. A 64-year-old male had chronic diabetic peripheral neuro-
pathic pain in both his feet for about 2 years. The patient tried multiple pain medications and var-
ious interventional pain treatments without signiﬁcant pain relief. After 4 weeks of whole body
vibration treatment the patient’s pain level and gait patterns signiﬁcantly improved. These ﬁndings
illustrate the importance of considering whole body vibration as a complimentary treatment in
patients with diabetic peripheral neuropathic pain.
 2011 International Journal of Diabetes Mellitus. Published by Elsevier Ltd. All rights reserved.1. Introduction
Peripheral small ﬁber neuropathy is characterized by the pres-
ence of lesions on or dysfunction of the small nerve ﬁbers,
which innervate the epidermis. This disorder can affect both
autonomic and somatic nerve ﬁbers, and therefore presents a
wide variety of symptoms ranging from pain and tingling sen-
sations (somatic lesions) to skin discolorations, atrophy and370 6240; fax: +1 503 370
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lseviersweat gland malfunction (autonomic lesions) [1]. These symp-
toms can also range anywhere from severe pain to mild tin-
gling sensation or slight numbness.
Peripheral small ﬁber neuropathy is relatively common,
affecting 1% of the world population, and 50% of the elderly
diabetic population [2]. Due to its prevalence, diabetic periph-
eral neuropathy (DPN) is considered an epidemic, especially
due to the fact that the number of people who are elderly
and diabetic are quickly on the rise.
Treatment options for DPN are extremely limited; most
treatment approaches focus on control of the patient’s diabetes
in order to prevent the DPN from getting worse. The only non-
prophylactic treatments available are powerful medications
such as antidepressants and antiepileptics [3]. There is only
one drug approved by the Food and Drug Administration
(FDA) speciﬁcally for treatment of DPN, and it is a powerful
neurotransmitter reuptake inhibitor [4]. These medications are
not a favorable treatment protocol for chronic conditions such
as DPN, because the side effects they cause can become more
debilitating than the original pathology.
Figure 1 Changes in pain perception before WBV treatment
over the study period.
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therapeutic modality, only having been used previously for
strength, conditioning and neuromuscular training purposes.
While whole-body-vibration recently has been shown to im-
prove strength and balance in clinical population with stroke,
ﬁbromyalgia, and Parkinson’s disease [5–7], it has yet to be ap-
plied as a treatment method for controlling pain and improv-
ing mobility disorders. The purpose of this study was to
describe a case of type II diabetic peripheral small ﬁber neu-
ropathy with whole body vibration therapy after a failed trial
of conventional drugs and interventional pain management.
2. Description of case
A 64-year old male in Salem, Oregon, USA, diagnosed with
type II diabetes six years previously, was recruited for this
study two months after his physician conﬁrmed diabetic
peripheral neuropathy (DPN). The patient reported that he
was active every day but was often unable to put pressure on
his feet and would have to sit or lay down to relieve the pain.
The only treatment he was receiving for DPN was taking acet-
aminophen (Tylenol) daily to control his pain, although this
was not always effective. As an inclusion criterion and a
screening process, his foot pain (both feet) was assessed with
the neuropathy pain scale. He was instructed not to change
his normal activity patterns during the study. The study was
approved by the IRB and informed consent was obtained be-
fore any intervention.
The patient received four bouts of 3 min of vibration treat-
ment (total 12 min) at 20 Hz ﬁve times a week for four weeks.
The patient wore socks during treatment and stood with both
feet on the platform, knees slightly bent for almost all bouts.
Every week, the Neuropathy Pain Scale (NPS) variables were
evaluated both pre and post treatment: intensity, sharpness,
hot, dull, cold, sensitivity, itchy, unpleasant, deep and surface.
During every day of treatment the patient reported the pain in
each foot on a Visual Analog pain Scale, or VAS. Each week
the patient’s gait was analyzed on 8 m GAITRITE mat (CIR
Systems, Clifton, NJ, USA). The patient’s stride and step
length, toe in/out, step and stride width, gait cycle time, step
time, ambulation time, velocity and distance traveled were
recorded.
3. Results
After 4 weeks of vibration treatment, the patient’s pain in both
feet decreased and gait improved signiﬁcantly. One week after
the treatment ended, the patient reported that the pain in both
feet was still signiﬁcantly lower than before treatment; his right
foot was 1 on the VAS and his left foot 2. Two weeks after
treatment had ended the patient reported that both feet were
around 2–3 on the VAS. This indicates that, while pain may
slowly return after a long period of time, whole body vibration
has positive long term effects on neuropathic pain.
4. Discussion
The results of this study indicate that whole body vibration re-
duces both acute and long-term pain in diabetics suffering
from peripheral neuropathy. Due to the nature of peripheralneuropathy, ﬁnding a cure is unrealistic. Thus, ﬁnding a treat-
ment to relieve symptoms is a more pragmatic approach to this
condition. Whole body vibration is a treatment option that can
reduce pain, and improve ability to participate in activities and
over-all quality of life for DPN sufferers. It is a non-invasive
treatment and has no known side effects.
Over the course of the treatment this therapy showed a sig-
niﬁcant reduction in reported VAS (Fig. 1). It also showed a
signiﬁcant reduction in all monitored NPS variables (Fig. 2).
We chose to only display the intensity, sharpness, unpleasant-
ness and deep pain, due to the fact that these were the only
variables that were relevant to this case. Other NPS variables
were monitored but no signiﬁcant results were found.
The result of our case study revealed a notable acute pain
reduction after each vibration treatment. The pain level
(Fig. 4) measured immediately after each treatment was aver-
aged 2.68 and 1.20 for the right and left foot, respectively
(Fig. 3). With this signiﬁcantly reduced pain level, we also mea-
sured how long this immediate effect would last. The results
showed that pain was reduced after each therapy session for
an average of three hours and that the level of pain, which re-
turned after this period was still reduced compared to the ori-
ginal pain level (Fig. 4). This is clinically signiﬁcant due to the
fact that most neuropathy patients yearn for some level of pain
relief and because pain level is so closely associated with the
patients’ quality of life.
One of the plausible mechanisms by which whole body
vibration reduces pain can be found in both peripheral and
central mechanisms. According to the gate control theory of
pain, the strength of synaptic transmission at the dorsal horn
and, similarly, at the trigeminal ganglia junctions is decreased,
probably by pre-synapatic inhibition, when large, non-pain-
signaling axons within the nerve are stimulated [8]. These are
touch receptors and vibration receptors (Pacinian corpuscles
and Meissner’s corpuscles). According to Longe et al. in a dis-
cussion postulating the responsible mechanism for pain reduc-
tion by vibration ‘‘The mechanism of action of these
procedures is generally explained by the gate-control theory
of pain inhibition in which large diameter sensory ﬁbers (A–
b), conducting impulses from the selective activation of low
threshold mechanoreceptors, reduce the painful input of the
small diameter nociceptive afferents (C-ﬁbers) by triggering lo-
cal inhibitory circuits in the substantia gelosa of the dorsal
horn’’ [9]. In the cat model, vibration has also shown to inhibit
nociceptive receptors in the dorsal horn neuron [10]. Acting in
a central location, vibrotactile and pain sensations are known
Figure 2 Changes in speciﬁc neuropathic pain variables in both
feet.
Figure 4 Changes in acute pain reduction duration over the
study period.
Figure 3 Changes in acute pain reduction over the study period.
Table 1 Changes in gait parameters after 4 weeks of vibration
therapy.
Pre Post
Ambulation time (s) 4.44 3.7
Velocity (cm/s) 99.10 119.80
Cadence (steps/min) 108.10 113.5
Step time
L 0.55 0.52
R 0.56 0.55
Cycle time
L 1.11 1.05
R 1.11 1.06
Swing times
L 0.38 0.38
R 0.39 0.40
Step length
L 55.26 64.05
R 54.71 62.74
Stride length
L 111.47 128.74
R 110.21 127.20
Base of support
L 12.00 8.00
R 12.08 10.52
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sory cortices of the brain [11].
Regarding the interaction of vibration and pain, Kakigi
and Shibasaki conﬁrm the role of vibration in alleviating pain
[12]. In a later study Kakigi and Watanabe show that both the
gate control theory and diffuse noxious inhibitory control ac-
counted for the pain relief following CO2 laser stimulation,
rather than simple changes in the subjects’ attention [13].
The authors suggested that the vibratory pain relief effect is
not simply at the level of the dorsal horn but also in the brain.
They further explained that the responsible sites for this phe-
nomenon are the dorsal horn of the spinal cord, the brainstem
and some parts of the brain such as the second sensory cortex
and the cingulate cortex.As well as improving quality of life in patients by reducing
pain,WBValso has great potential to reduce their risk of serious
injury. The gait variables examined before and after 4 weeks of
vibration therapy (Table 1) showed that the patient’s gait nota-
bly improved in most of the variables. Step time, stride length,
and cadence all increased, and gait velocity and ambulation time
decreased. Speciﬁcally, the coefﬁcient of variations of temporal
gait variables was decreased indicating that the gait of the pa-
tient became more consistent. The idea that WBV can improve
conﬁdence in gait makes it a desirable treatment option consid-
ering the majority of DPN patients are elderly and are prone to
falls, and at a higher risk of injury [14,15].
This study indicates that the whole body vibration treat-
ment reduces neuropathic pain, and improves gait in a patient
with type II diabetic peripheral neuropathy. Although, re-
search on this topic is in its infancy, the incorporation of whole
body vibration into other therapeutic treatment protocols for
diabetic peripheral neuropathy patients may offer promise.
In this single subject study, possible placebo and learning ef-
fects cannot be completely excluded. Our report is intended
to further a discussion about the possible use of whole body
vibration in patients with diabetic peripheral neuropathic pain.
Whole body vibration treatment warrants further investigation
over the course of a longer, prospective study; in addition, long
term follow up is required to help us understand if any side ef-
fects are associated with this possible therapeutic modality.Acknowledgments
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